𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiproliferative effects of bacillus Calmette-Guérin and interferon α2b on human bladder cancer cells in vitro

✍ Scribed by Kimberley Pryor; Phillip Stricker; Pamela Russell; David Golovsky; Ronald Penny


Publisher
Springer-Verlag
Year
1995
Tongue
English
Weight
821 KB
Volume
41
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Effects of bacillus Calmette-Guérin and
✍ Ye Zhang; Hoon Eng Khoo; Kesavan Esuvaranathan 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 160 KB

The cytolytic and anti-proliferative effects of bacillus Calmette-Gue ´rin (BCG) and/or interferon-a-2b (IFN-a-2b) on 5 human bladder carcinoma cell lines, RT4, RT112, MGH, SD and J82, were determined. The cell lines showed different sensitivities to BCG and IFN-a-2b. BCG had direct dosedependent cy

Cytostatic effect of different strains o
✍ Rajala, P. ;Kaasinen, E. ;Rintala, E. ;Jauhiainen, K. ;Nurmi, M. ;Alfthan, O. ;L 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 312 KB

The cytostatic activity of five Bacillus Calmette-Guérin (BCG) strains (Pasteur, Evans, Tice, RIVM and Connaught) on human transitional cell cancer T24 cells was examined. A striking effect was noted even in 2-day cultures, and the effect was more pronounced when the cells were incubated for 5 days

Effects of bacillus calmette-guerin on c
✍ Youichi Mizutani; Yoshinori Nio; Manabu Fukumoto; Osamu Yoshida 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 867 KB

The effects of bacillus Calmette-Guerin (BCG) on the cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer were analyzed in a 12-hour chromium 51 ( 51Cr) relea

Recombinant human leukocyte interferon-α
✍ S. Iacobelli; G. Scambia; C. Natoli; P. Benedetti Panici; G. Baiocchi; L. Perron 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 322 KB

We have previously reported the production of a new monoclonal antibody (MAb) (SP-2) recognizing a 90-kDa tumorassociated antigen, termed 9OK. which is increased in the serum of many cancer patients. Treatment of CG5 human breast cancer cells with recombinant interferon-a 2b (rlFN-a 2b) can increase